Ads
related to: sickle cell disease treatments- Treatment Journey
See the treatment journey
Step by step.
- Treatment Journey Video
See the treatment journey
video on the HCP website.
- Resources
Downloadable HCP brochure
and more professional resources.
- About The Therapy
The science behind the disease
and this treatment option.
- Mechanism of Action Video
Watch an MOA video on the
official HCP website.
- Stay Informed
Sign up to receive updates
as they become available.
- Treatment Journey
Search results
Results From The WOW.Com Content Network
The Food and Drug Administration on Friday approved a powerful treatment for sickle cell disease, a devastating illness that affects more than 100,000 Americans, the majority of whom are Black.
Federal officials Friday approved two gene therapy treatments for sickle cell disease, welcome news for thousands with the inherited blood disorder that causes terrible pain crises and early...
When treating avascular necrosis of the bone in people with sickle cell disease, the aim of treatment is to reduce or stop the pain and maintain joint mobility. Current treatment options include resting the joint, physical therapy, pain-relief medicine, joint-replacement surgery, or bone grafting.
Exagamglogene autotemcel, sold under the brand name Casgevy, is a gene therapy used for the treatment of sickle cell disease and transfusion-dependent beta thalassemia. It was developed by Vertex Pharmaceuticals and CRISPR Therapeutics.
The FDA is reviewing a new drug for sickle cell disease that uses CRISPR to edit DNA. Black patients with the disease are excited and hopeful about the treatment.
Voxelotor, sold under the brand name Oxbryta, is a medication used for the treatment of sickle cell disease. Voxelotor is the first hemoglobin oxygen-affinity modulator. Voxelotor has been shown to have disease-modifying potential by increasing hemoglobin levels and decreasing hemolysis indicators in sickle cell patients.
Ads
related to: sickle cell disease treatments